The incidence of adverse events, ranked from highest to lowest, was as follows: thrombocytopenia, elevated total bilirubin, leukopenia, elevated AST, prolonged PT, hypothyroidism, elevated ALT, progression of Child-Pugh scores, and progression of ALBI scores. This evidence concerns the gene F2 and Decreased total leukocyte count.